JP Morgan Chase
CYNA

JP Morgan Chase’s CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) CYNA Stock Holding History

JP Morgan Chase’s Portfolio CYNA Stock Details CYNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-24,834
Closed -$999K – 5313
2016
Q3 		$999K Buy
+24,834
New +$613K ﹤0.01% 3136

JP Morgan Chase's CYNA Position: Q4 2016 in Review

JP Morgan Chase sold out of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) in Q4 2016, closing a stake of 24,834 shares — an estimated $999K sold.

JP Morgan Chase first reported a position in CYNA in Q3 2016 and held it in 1 quarter. The position peaked at $999K in Q3 2016. 0 funds tracked by Wall St. Rank hold CYNA as of Q4 2016.

  • JP Morgan Chase reported no remaining CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position as of Q4 2016 after selling out during the quarter.
  • JP Morgan Chase sold 24,834 CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) shares in Q4 2016, an estimated $999K.
  • JP Morgan Chase first reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in Q3 2016 and held it in 1 quarter.
  • JP Morgan Chase's CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) position peaked at $999K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) as of Q4 2016.

Based on JP Morgan Chase's 13F filing for Q4 2016, filed 6 Feb 2017.